194 related articles for article (PubMed ID: 11720635)
1. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
Hamilton SF; Houle LM; Thadani U
Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
[TBL] [Abstract][Full Text] [Related]
2. Nisoldipine coat-core and heart rate response during treatment of hypertension.
Zannad F
Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
[TBL] [Abstract][Full Text] [Related]
3. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
Langtry HD; Spencer CM
Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
[TBL] [Abstract][Full Text] [Related]
4. Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.
Plosker GL; Faulds D
Drugs; 1996 Aug; 52(2):232-53. PubMed ID: 8841741
[TBL] [Abstract][Full Text] [Related]
5. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
Fodor JG
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
[TBL] [Abstract][Full Text] [Related]
6. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release calcium channel antagonists in cardiovascular disease: pharmacology and current therapeutic use.
Silvestry FE; St John Sutton MG
Eur Heart J; 1998 Aug; 19 Suppl I():I8-14. PubMed ID: 9743438
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form.
Schaefer HG; Heinig R; Ahr G; Adelmann H; Tetzloff W; Kuhlmann J
Eur J Clin Pharmacol; 1997; 51(6):473-80. PubMed ID: 9112062
[TBL] [Abstract][Full Text] [Related]
11. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Chen YH; Liu RC; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction.
Lewis BS
Am J Cardiol; 1995 Apr; 75(13):46E-53E. PubMed ID: 7726125
[TBL] [Abstract][Full Text] [Related]
13. The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine.
Gradman AH
Can J Cardiol; 1995 Apr; 11 Suppl B():14B-21B. PubMed ID: 7728649
[TBL] [Abstract][Full Text] [Related]
14. Nisoldipine CC: clinical experience in hypertension.
Langan J; Rodríguez-Mañas L; Sareli P; Heinig R
Cardiology; 1997; 88 Suppl 1():56-62; discussion 63-5. PubMed ID: 9118169
[TBL] [Abstract][Full Text] [Related]
15. Nisoldipine--a new calcium channel blocker for hypertension.
Med Lett Drugs Ther; 1996 Feb; 38(968):13-4. PubMed ID: 8592476
[TBL] [Abstract][Full Text] [Related]
16. Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.
Glasser SP
Am J Cardiol; 1995 Apr; 75(13):68E-70E. PubMed ID: 7726128
[TBL] [Abstract][Full Text] [Related]
17. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Friedel HA; Sorkin EM
Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic agents in the management of hypertension--nisoldipine coat-core.
White WB
J Clin Hypertens (Greenwich); 2007 Apr; 9(4):259-66. PubMed ID: 17396068
[TBL] [Abstract][Full Text] [Related]
19. Mibefradil, a pharmacologically distinct calcium antagonist.
Ernst ME; Kelly MW
Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
[TBL] [Abstract][Full Text] [Related]
20. Current recommendations for the treatment of hypertension: are they still valid?
Moser M
J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
